Otsuka Holdings Co., Ltd.

Pharmaceuticals
Japan
Executive 1Akihiko Otsuka, Chairman; | Chairman;
Executive 2Ichiro Otsuka, Vice-Chairman; | Honorary Chairman;
Earnings Per Share Growth (%)25.34%
Cost of Goods Sold (US$ Millions)$3,701
Current Liabilities (US$ Millions)$4,338
Total Assets (US$ Millions)$9,796
Long Term Debt (Millions)$120
Return on Equity11.25%
Revenue (US$ Millions)$12,176
Total Company Assets$17,001
Revenue Growth (%)19.27%
Net Income (US$ Millions)$1,265
Earnings Per Share (US$)$2.33
Total Equity (US$ Millions)$12,056
Profit Margin (%)10.39%
Debt To Equity Ratio (%)0.01%
Inventories (Millions)$1,273